TLDR Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.
The study synthesized and characterized a series of 5α, 6β-Dichloro-17-Oxoandrostan-3β-yl esters (7a-7f) to evaluate their 5α-reductase inhibitory activity. The compounds demonstrated increased anti-androgenic activity compared to finasteride, with compound 7b showing the highest inhibitory activity and improved solubility and dissolution properties. These findings suggest that the presence of an electronegative group at position 3 enhances the activity, making compound 7b a promising candidate for further development and formulation against benign prostatic hyperplasia and prostate cancer.
17 citations
,
December 2015 in “Bioorganic & Medicinal Chemistry”
72 citations
,
January 2011 in “Current Pharmaceutical Design” S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.
23 citations
,
February 2010 in “European Journal of Medicinal Chemistry”
16 citations
,
January 2010 in “Drug Metabolism and Pharmacokinetics” Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.
49 citations
,
January 2004 in “Journal of steroid biochemistry and molecular biology/The Journal of steroid biochemistry and molecular biology” Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.
19 citations
,
December 2002 in “Journal of Liquid Chromatography & Related Technologies” New method quickly and accurately measures finasteride in tablets.
22 citations
,
January 2001 in “Chemical & Pharmaceutical Bulletin” Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.
19 citations
,
June 1999 in “Steroids” Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.
64 citations
,
June 1995 in “Steroids” Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.
211 citations
,
November 1990 in “The Journal of Steroid Biochemistry and Molecular Biology” Finasteride effectively treats BPH, but needs more trials to understand potential.